1. Home
  2. NBY vs BX Comparison

NBY vs BX Comparison

Compare NBY & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.18

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Logo Blackstone Inc.

BX

Blackstone Inc.

HOLD

Current Price

$109.94

Market Cap

116.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
BX
Founded
2000
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
116.4B
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
NBY
BX
Price
$1.18
$109.94
Analyst Decision
Buy
Analyst Count
0
16
Target Price
N/A
$169.50
AVG Volume (30 Days)
818.4K
9.0M
Earning Date
03-31-2026
04-16-2026
Dividend Yield
N/A
4.18%
EPS Growth
35.42
6.91
EPS
0.76
3.87
Revenue
$370,000.00
$14,450,265,000.00
Revenue This Year
$23.91
$14.56
Revenue Next Year
$32.05
$21.82
P/E Ratio
$1.59
$29.32
Revenue Growth
N/A
9.22
52 Week Low
$0.43
$101.73
52 Week High
$19.95
$190.09

Technical Indicators

Market Signals
Indicator
NBY
BX
Relative Strength Index (RSI) 42.06 40.79
Support Level $0.99 $103.41
Resistance Level $1.36 $165.14
Average True Range (ATR) 0.18 4.27
MACD 0.11 1.41
Stochastic Oscillator 8.11 57.91

Price Performance

Historical Comparison
NBY
BX

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

Share on Social Networks: